JACOBS LEVY EQUITY MANAGEMENT, INC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,924,587
-24.9%
373,117
-32.1%
0.10%
-23.1%
Q2 2023$22,548,365
+17.6%
549,558
+2.4%
0.13%
+10.2%
Q1 2023$19,181,229
-26.4%
536,688
-22.2%
0.12%
-33.0%
Q4 2022$26,050,763
+15.0%
689,721
+34.7%
0.18%
-1.7%
Q3 2022$22,645,000
-0.8%
511,975
-17.0%
0.18%
+1.1%
Q2 2022$22,833,000
-61.9%
616,766
-61.9%
0.18%
-56.1%
Q1 2022$59,941,000
+40.0%
1,618,267
+15.0%
0.40%
+40.4%
Q4 2021$42,827,000
+7.2%
1,407,388
+18.1%
0.29%
+6.7%
Q3 2021$39,954,000
-7.6%
1,191,236
+9.8%
0.27%
-8.2%
Q2 2021$43,258,000
+490.5%
1,084,422
+565.5%
0.29%
+414.0%
Q1 2021$7,326,000
-36.5%
162,946
-20.2%
0.06%
-43.6%
Q4 2020$11,544,000
+62.8%
204,181
+36.6%
0.10%
+36.5%
Q3 2020$7,092,000
-23.6%
149,472
-5.1%
0.07%
-26.7%
Q2 2020$9,286,000
+86.0%
157,499
+49.2%
0.10%
+57.8%
Q1 2020$4,992,000
-2.5%
105,577
+24.6%
0.06%
+28.0%
Q4 2019$5,118,000
-45.5%
84,724
-46.0%
0.05%
-56.5%
Q3 2019$9,396,000
+30.4%
156,840
+39.9%
0.12%
+15.0%
Q2 2019$7,203,000
+68.4%
112,070
+112.7%
0.10%
+61.3%
Q1 2019$4,277,000
+34.2%
52,690
-61.5%
0.06%
-6.1%
Q2 2016$3,188,000136,9000.07%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders